• Ranbaxy Inc., of Gurgaon, India, initiated a voluntary recall of 41 affected lots of atorvastatin calcium tablets as a precautionary measure due to the fact that the firm said it cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand.